Source: Globiox Blog

Globiox Blog Combined use diagnostic instruments and the FDA’s thoughts

The FDA has recently released a draft guidance entitled “Molecular Diagnostic Instruments with Combined Functions.” The recommendations display intent to mitigate interference in molecular diagnostic instruments with combined FDA approved device functions and functions in which FDA approval is not required, and furthermore prevent confusion for the end user. While following the guideline should serve…Read More

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Patti Rossman's photo - CEO of Globiox

CEO

Patti Rossman

CEO Approval Rating

- -/100

Read more